Cargando…
DEFB4A is a potential prognostic biomarker for colorectal cancer
Colorectal cancer (CRC) is the third leading cause of cancer-associated mortality. The present study aimed to investigate novel biomarkers to predict prognosis and provide a theoretical basis for studies of the pathogenesis and the development of therapies for CRC. The present study compared mRNA ex...
Autores principales: | Wu, Qian, Wang, Dan, Zhang, Zhen, Wang, Yaping, Yu, Weina, Sun, Kai, Maimela, Nomathamsanqa Resegofetse, Sun, Zhenqiang, Liu, Jinbo, Yuan, Weitang, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448564/ https://www.ncbi.nlm.nih.gov/pubmed/32863927 http://dx.doi.org/10.3892/ol.2020.11975 |
Ejemplares similares
-
Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
por: Wang, Dan, et al.
Publicado: (2019) -
Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
por: Wang, Dan, et al.
Publicado: (2021) -
Fates of CD8+ T cells in Tumor Microenvironment
por: Maimela, Nomathamsanqa Resegofetse, et al.
Publicado: (2018) -
Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients
por: Liu, Chaojun, et al.
Publicado: (2020) -
MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer
por: Yang, Shuaixi, et al.
Publicado: (2018)